51 results
Page 3 of 3
F-1/A
so7iv5rw5ch3o0h2hec
19 Mar 20
Registration statement (foreign) (amended)
12:21pm
424B5
b92safahuo9baa 7n
5 Dec 19
Prospectus supplement for primary offering
5:29pm
6-K
EX-99.1
ysuv y7za5fd2ybsg
31 Jul 19
Therapix Biosciences Announces Canadian Product LicenseĀ Issuance for TheraPEA (CannAmideā¢), a Non-Opiate Based Pain Management Supplement
4:03pm
424B5
cr4ae 4qtldh6smp4
1 Apr 19
Prospectus supplement for primary offering
6:57am
6-K
jfm o6zth75q
26 Mar 19
Report of Foreign Private Issuer
4:08pm
424B2
d2n6xw8u01
9 Aug 18
Prospectus for primary offering
11:19am
F-3/A
zv4 9x6e0hja1ajsjayi
17 Jul 18
Shelf registration (foreign) (amended)
1:29pm
F-3
81d7fmu
20 Jun 18
Shelf registration (foreign)
2:38pm
6-K
EX-99.1
9mr m6fgkf7abw07
6 Jun 18
Therapix Biosciences Reports First Quarter 2018 Financial Results and Provides Business Update
4:55pm
20-F
43qopn c10gj
1 May 17
Annual report (foreign)
12:00am